- Home
- LNTH vs PATH Comparison
LNTH vs PATH Comparison
Compare LNTH & PATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- PATH
- Stock Information
- Founded
- LNTH 1956
- PATH 2005
- Country
- LNTH United States
- PATH United States
- Employees
- LNTH N/A
- PATH N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- PATH Computer Software: Prepackaged Software
- Sector
- LNTH Health Care
- PATH Technology
- Exchange
- LNTH Nasdaq
- PATH Nasdaq
- Market Cap
- LNTH 7.5B
- PATH 7.1B
- IPO Year
- LNTH 2015
- PATH 2021
- Fundamental
- Price
- LNTH $79.19
- PATH $12.19
- Analyst Decision
- LNTH Strong Buy
- PATH Hold
- Analyst Count
- LNTH 5
- PATH 18
- Target Price
- LNTH $133.80
- PATH $13.97
- AVG Volume (30 Days)
- LNTH 1.0M
- PATH 13.6M
- Earning Date
- LNTH 07-30-2025
- PATH 05-29-2025
- Dividend Yield
- LNTH N/A
- PATH N/A
- EPS Growth
- LNTH N/A
- PATH N/A
- EPS
- LNTH 3.53
- PATH N/A
- Revenue
- LNTH $1,536,699,000.00
- PATH $1,451,176,000.00
- Revenue This Year
- LNTH $4.63
- PATH $10.73
- Revenue Next Year
- LNTH $9.35
- PATH $8.72
- P/E Ratio
- LNTH $22.44
- PATH N/A
- Revenue Growth
- LNTH 12.53
- PATH 7.21
- 52 Week Low
- LNTH $73.11
- PATH $9.38
- 52 Week High
- LNTH $126.89
- PATH $15.93
- Technical
- Relative Strength Index (RSI)
- LNTH 44.57
- PATH 43.26
- Support Level
- LNTH $76.34
- PATH $12.17
- Resistance Level
- LNTH $84.36
- PATH $12.59
- Average True Range (ATR)
- LNTH 2.69
- PATH 0.39
- MACD
- LNTH 0.66
- PATH -0.14
- Stochastic Oscillator
- LNTH 48.07
- PATH 9.95
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About PATH UiPath Inc.
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.